ETC
FHTX icon

Exchange Traded Concepts’s Foghorn Therapeutics FHTX Stock Holding History

Exchange Traded Concepts’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,693
Closed -$101K – 1438
2025
Q1 		$101K Buy
27,693
+9,608
+53% +$43.8K ﹤0.01% 1159
2024
Q4 		$85.4K Hold
18,085
– – ﹤0.01% 1173
2024
Q3 		$168K Sell
18,085
-17,836
-50% -$129K ﹤0.01% 1016
2024
Q2 		$207K Sell
35,921
-11,176
-24% -$66.6K 0.01% 872
2024
Q1 		$316K Buy
47,097
+25,562
+119% +$142K 0.01% 780
2023
Q4 		$139K Buy
21,535
+5,460
+34% +$23.6K ﹤0.01% 841
2023
Q3 		$80.4K Sell
16,075
-396
-2% -$3.05K ﹤0.01% 960
2023
Q2 		$116K Buy
+16,471
New +$115K ﹤0.01% 918

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Exchange Traded Concepts's FHTX Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Foghorn Therapeutics (FHTX) in Q2 2025, closing a stake of 27,693 shares — an estimated $101K sold.

Exchange Traded Concepts first reported a position in FHTX in Q2 2023 and held it in 8 quarters. The position peaked at $316K in Q1 2024. 81 funds tracked by Wall St. Rank hold FHTX as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Foghorn Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 27,693 Foghorn Therapeutics shares in Q2 2025, an estimated $101K.
  • Exchange Traded Concepts first reported a position in Foghorn Therapeutics in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Foghorn Therapeutics position peaked at $316K in Q1 2024.
  • 81 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.